Investment Stage

Focus Areas

About Investor

Claire Brown serves as a Partner in Life Sciences at Oxford Science Enterprises. Based in Oxford, she concentrates on Seed-stage BioTech businesses at the beginning of their commercial journey. She evaluates scientific discoveries, management teams, development plans, and the potential pathway from research to a viable biotechnology company. Her investment range is between $650K and $26M, with a preferred ticket of around $6M. As a lead investor, she helps shape early financing rounds and supports companies as they build teams, programs, and operating strategies. Her work often begins when a scientific concept is promising but still requires capital and structured company-building support. Through Oxford Science Enterprises, she helps establish new biotechnology ventures around high-potential research.